Connect Biopharma Holdings Limited Ordinary Shares

CNTBNASDAQ • USD
0.78 USD
↘ 0.02 (2.77%)🟢LIVE (AS OF 02:23 PM EST)
🟢Market: OPEN

Shares of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) are trading at $0.78. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CNTB trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 30, 2026.

Open?$0.81
High?$0.85
Low?$0.77
Prev. Close?$0.80
Volume?297.5K
Avg. Volume?7.0M
VWAP?$0.79
Rel. Volume?0.04x
Bid / Ask
Bid?$0.67 × 100
Ask?$0.81 × 400
Spread?$0.14
Midpoint?$0.74
Valuation & Ratios
Market Cap?50.4M
Shares Out?63.0M
Float?20.7M
Float %?32.8%
P/E Ratio?N/A
P/B Ratio?1.88
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Employees
64
Market Cap
50.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-09-03
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200
SAN DIEGO, CA 92130
Phone: 858-727-1040
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
52
Piotroski F-Score?1/9Weak
Altman Z-Score?-16.93Distress
Confidence?57%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.67%High
Short Interest?3.9M
Days to Cover?1.7
Free Float20.7M
Avg Daily Volume2.2M
Settlement Date2026-10-15
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?1.66Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
77
1.88CHEAP▾
P/S?
Peers
100
S&P
3
17.06HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
Peers
100
S&P
17
7.91HIGH▾
Returns & Efficiency
ROE?
S&P
3
-257.9%WEAK▾
ROA?
S&P
3
-159.4%WEAK▾
Cash Flow & Enterprise
FCF?$-60633000
Enterprise Value?$23.4M
Fundamentals ratios updated end of day